by Sara M. Nolte | Jan 19, 2015
. If you’ve been on the Internet at all in 2015, you’ve probably stumbled across headlines like “Two-thirds of cancers are due to ‘back luck,’ study finds” (CBSNews), “Most cancers are caused by bad luck not genes or lifestyle say scientists” (The Telegraph), “Cause...
by Lisa Willemse | Jan 16, 2015
> There are few things in Canada that grab national attention than a story related to hockey. News that surfaced last month that hockey legend Gordie Howe had received an unproven stem cell therapy for stroke continue to grab headlines in this country. In the past...
by Mark Curtis | Jan 13, 2015
. Welcome to your Update from the Clinic for the month of December. bluebird bio’s first four patients are transfusion-free after treatment with its gene therapy Lentiglobin. Fate Therapeutics’ hematopoietic stem cell-modulating technology ProHema seems to be on track...
by Stacey Johnson | Jan 9, 2015
. Alzheimer’s disease is a chronic, neurodegenerative disease characterized by loss of memory and changes in behaviour in the early stage. It typically starts slowly and progresses, within a decade, to death from an external factor, such as an infection or pneumonia,...
by Mark Curtis | Jan 7, 2015
. Welcome to your deal review for the month of December. Juno Therapeutics made its leap into the public realm with the largest biotech initial public offering (IPO) in 2014. bluebird Bio announced pricing of a common offering to raise over $200M. Read on to find out...
by Peter Raaymakers | Jan 2, 2015
One of the most common New Year’s Resolutions made every year: Exercise regularly and get in better shape. It’s a noble resolution, often broken, but worthwhile nonetheless. But have you ever wondered how that resolution works? Wonder no more: This great...
by Peter Raaymakers | Dec 26, 2014
In a TED video from earlier in the year, Nina Tandon and Sarindr Ick Bhumiratana of EpiBone talked about their incredible technique to use biomaterials and stem cells to generate customized bone material for implant. In Tandon’s words, “If you need a piece...
by Mark Curtis | Dec 23, 2014
. Welcome to your Update from the Clinic for the month of November. NeoStem announced initial positive data from its Phase 2 study in acute myocardial infarction. Neuralstem’s human neural stem cells are shown to have long-term viability following transplant, while...
by Stacey Johnson | Dec 19, 2014
. Ah, the holidays. Fodder for journalists and bloggers alike. Last year, I brought you two themed blogs: an idea for a unique Christmas present – by the way, it’s on sale if you order now – and a list of movies and TV shows “about” regenerative medicine (RM) to watch...
by James Smith | Dec 18, 2014
. With contributions from David Brindley Manufacturing may not be the first thing that springs to mind when regenerative medicine is mentioned. Most will think of the enormous potential for cell therapies or transplantation or editing of faulty genes. However, having...
Comments